MENU
FATE
AS OF
Dec 24 closing price
Price
$1.01
Change
+$0.03 (+3.06%)
Capitalization
116.51M
67 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
FATE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Fate Therapeutics (FATE) Ownership - Who owns Fate Therapeutics?

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
220
Web
https://www.fatetherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
116.51M
P/E Ratio
N/A
Total Cash
215.42M
Projected Growth
N/A
Total Debt
79.25M
Revenue
7.14M
Risk (Beta)
3.42
Dividend Yield
N/A
Total Cash/Share
1.87
Total Debt/Equity
2.75
Revenue/Share
0.06 USD as % of share price

Fundamentals

FATE
Capitalization
117M
P/E Ratio
N/A
Risk (Beta)
3.42
Dividend Yield
N/A
Total Cash
215M
Total Cash/Share
1.87
Total Debt
79.2M
Total Debt/Equity
2.75
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.06%
Revenue
7.14M
ROE
N/A
Book Value
234M
P/B Ratio
0.50
Cash Flow
N/A
Earnings
-1.33
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
115K
Current Ratio
7.87
Current Revenue Per Employee
9618.78
Dividends Per Share - Security
N/A
EBITDA
-145.34M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-37.23
Shares Held By Institutions
147M
Shares Outstanding - Current
115M
Total Liabilities
110M
Total Volume MTD
N/A
Value
1
Gain YTD
-38.788
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
FATE
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FATE showed earnings on November 13, 2025. You can read more about the earnings report here.
View AI-Driven Trading for FATE
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
220
Web
https://www.fatetherapeutics.com